117 related articles for article (PubMed ID: 33215823)
1. A case of bevacizumab-induced non-remitting thrombotic microangiopathy.
Wong YHS; Sinniah R; Rosman J
Intern Med J; 2020 Nov; 50(11):1432-1434. PubMed ID: 33215823
[No Abstract] [Full Text] [Related]
2. Renal thrombotic microangiopathy caused by bevacizumab.
Horino T; Ichii O; Shimamura Y; Terada Y
Nephrology (Carlton); 2018 Apr; 23(4):378-379. PubMed ID: 29520904
[No Abstract] [Full Text] [Related]
3. A severe case of bevacizumab-induced thrombotic microangiopathy.
Bektas M; Samancı NS; Cokgezer S; Keskin D; Demirelli FH
J Oncol Pharm Pract; 2019 Oct; 25(7):1754-1757. PubMed ID: 30253727
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous ulcer with thrombogenic vasculopathy in a patient receiving bevacizumab.
Vila-Payeras A; Iglesias-González M; Terrasa-Sagristá F; Parera-Amer E
Indian J Dermatol Venereol Leprol; 2021; 87(2):268-270. PubMed ID: 33769753
[No Abstract] [Full Text] [Related]
5. Bevacizumab-associated glomerular microangiopathy.
Person F; Rinschen MM; Brix SR; Wulf S; Noriega MLM; Fehrle W; Schmitz J; Schwarz A; Ivanyi P; Steinmetz OM; Reinhard L; Hoxha E; Zipfel PF; Bräsen JH; Wiech T
Mod Pathol; 2019 May; 32(5):684-700. PubMed ID: 30552416
[TBL] [Abstract][Full Text] [Related]
6. Bevacizumab-induced thrombotic microangiopathy and nephrotic syndrome.
Shimamura Y; Maeda T; Takizawa H
Clin Exp Nephrol; 2019 Jan; 23(1):142-143. PubMed ID: 29882112
[No Abstract] [Full Text] [Related]
7. Anti-VEGF-related thrombotic microangiopathy in a child presenting with nephrotic syndrome.
Yılmaz S; Özçakar ZB; Taktak A; Kiremitçi S; Ensari A; Dinçaslan H; Yalçınkaya F
Pediatr Nephrol; 2016 Jun; 31(6):1029-32. PubMed ID: 26928310
[TBL] [Abstract][Full Text] [Related]
8. Bevacizumab-associated glomerular microangiopathy that occurred after postoperative chemotherapy for ovarian cancer.
Morimoto M; Arai T; Matsuura M; Ono Y
CEN Case Rep; 2021 Feb; 10(1):6-11. PubMed ID: 32642991
[TBL] [Abstract][Full Text] [Related]
9. Thrombotic microangiopathy related to anti-VEGF agents: intensive versus conservative treatment?
Izzedine H; Sène D; Hadoux J; Gharbi C; Bourry E; Massard C; Soria JC
Ann Oncol; 2011 Feb; 22(2):487-90. PubMed ID: 21278225
[No Abstract] [Full Text] [Related]
10. Drug induced thrombotic microangiopathy caused by levofloxacin.
Kazi S; Preston GC
J R Coll Physicians Edinb; 2018 Jun; 48(2):127-129. PubMed ID: 29992202
[TBL] [Abstract][Full Text] [Related]
11. Successful antemortem diagnosis and treatment of pulmonary tumor thrombotic microangiopathy.
Higo K; Kubota K; Takeda A; Higashi M; Ohishi M
Intern Med; 2014; 53(22):2595-9. PubMed ID: 25400181
[TBL] [Abstract][Full Text] [Related]
12. Biology of anti-angiogenic therapy-induced thrombotic microangiopathy.
Eremina V; Quaggin SE
Semin Nephrol; 2010 Nov; 30(6):582-90. PubMed ID: 21146123
[TBL] [Abstract][Full Text] [Related]
13. Cabozantinib-induced renal thrombotic microangiopathy.
La Manna G; Baraldi O; Corradetti V; Comai G
Nephrology (Carlton); 2018 Jan; 23(1):96-97. PubMed ID: 29250919
[No Abstract] [Full Text] [Related]
14. Renal-limited thrombotic microangiopathy after switching from bevacizumab to ramucirumab: a case report.
Yamada R; Okawa T; Matsuo K; Suzuki M; Mori N; Mori K
BMC Nephrol; 2019 Jan; 20(1):14. PubMed ID: 30634936
[TBL] [Abstract][Full Text] [Related]
15. Thrombotic microangiopathy associated with Valproic acid toxicity.
Hebert SA; Bohan TP; Erikson CL; Swinford RD
BMC Nephrol; 2017 Aug; 18(1):262. PubMed ID: 28774273
[TBL] [Abstract][Full Text] [Related]
16. Acute Thrombotic Microangiopathy and Cortical Necrosis Following Administration of Alemtuzumab: A Case Report.
Liou AA; Skiver BM; Yates E; Persad P; Meyer D; Farland AM; Rocco MV
Am J Kidney Dis; 2019 May; 73(5):615-619. PubMed ID: 30528935
[TBL] [Abstract][Full Text] [Related]
17. Clopidogrel-induced Thrombotic Microangiopathy in a Patient with Hypocomplementemia.
Tada K; Ito K; Hamauchi A; Takahashi K; Watanabe R; Uchida A; Abe Y; Yasuno T; Miyake K; Sasatomi Y; Nakashima H
Intern Med; 2016; 55(8):969-73. PubMed ID: 27086814
[TBL] [Abstract][Full Text] [Related]
18. Gemcitabine-induced renal thrombotic microangiopathy.
Horino T; Inotani S; Ishihara M; Terada Y
Nephrology (Carlton); 2022 Aug; 27(8):724-725. PubMed ID: 35429056
[No Abstract] [Full Text] [Related]
19. Sirolimus-related systemic thrombotic microangiopathy after renal transplantation.
Negrini S; Durrbach A; Becquemont L
Therapie; 2014; 69(2):175-7. PubMed ID: 24926637
[TBL] [Abstract][Full Text] [Related]
20. Thrombotic microangiopathy: COVID-19 or hydroxychloroquine?
Hasbal NB
Kidney Int; 2020 Dec; 98(6):1619-1620. PubMed ID: 32976850
[No Abstract] [Full Text] [Related]
[Next] [New Search]
